Department Of Neurology 6
251. Practices, Resources and Challenges in Parkinsons Disease Management in Asia: Movement Disorders in Asia Study Group Report
252. Practices, Resources and Challenges in Parkinsons Disease Management in Asia: Movement Disorders in Asia Study Group Report
253. Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021
254. The burden of diseases, injuries, and risk factors by state in the USA, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
255. The burden of diseases, injuries, and risk factors by state in the USA, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
256. Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004-2017
257. Age, Sex, and Ethnic Differences in Intracerebral Haemorrhage in Karaganda Region, Kazakhstan, 2018-2020
258. Unraveling the association between COL4A2 polymorphisms and intracerebral hemorrhage
259. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
260. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
261. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
262. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
263. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
264. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
265. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
266. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
267. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
268. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
269. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
270. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
271. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
272. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
273. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
274. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
275. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
276. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
277. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
278. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
279. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
280. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
281. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
282. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
283. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
284. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
285. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
286. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
287. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
288. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
289. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
290. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
291. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
292. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
293. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
294. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
295. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
296. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
297. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
298. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
299. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
300. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
1 4 5 6 7 8 13